home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Enzyme Associated with Vitamin B12 Levels

 
  September, 18 2008 8:17
your information resource in human molecular genetics
 
     
Scientists have identified the first genetic variants that contribute to variation in levels of vitamin B12, according to a study published online in Nature Genetics.

Vitamin B12 is found in meat and milk products, and is necessary for the formation of red blood cells. Deficiency of vitamin B12, whether due to direct dietary deficiency or inadequate absorption in the intestine, is associated with anaemia, cardiovascular disease, cancer, and neurodegenerative disorders.

David Hunter and colleagues carried out a genome-wide association study in search of common genetic variation that might influence plasma levels of B12. They found three highly correlated single-nucleotide polymorphisms (SNPs) in the gene FUT2 to be associated with B12 levels.

FUT2 encodes an enzyme that links certain types of sugars and that, among other things, regulates the secretion of the factors that constitute an individual's blood type. One of the B12-associated SNPs renders FUT2 nonfunctional, and has been referred to as the 'nonsecretor' variant because it prevents secretion of the blood-type factors. The 'secretor' version of FUT2 has been associated with infection by the bacterium Helicobacter pylori, which can cause gastritis. The authors suggest that genetic variation in FUT2 may influence B12 levels via H. pylori, which others have shown to be associated with B12 malabsorption.

Author contact:

David Hunter (Harvard School of Public Health, Boston, MA, USA)
E-mail: dhunter@hsph.harvard.edu

Abstract available online.

(C) Nature Genetics press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.